This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a McGill University directory, so their publications, courses and email address may be missing. Find their university profile.
Research
Latest funding
- $921,826
Enhanced Multi-modal, Patient-Centred treatment Option Pathway for Women Experiencing Sleep-Disordered Breathing in PRegnancy (EMPOWER-SDB): A Type 1 Hybrid Effectiveness-Implementation Trial
CIHR · 2026 · Co-investigator
- $2,945,248
Functional Outcomes, Lung health, and Livelihood Outcomes among people With Tuberculosis (FOLLOW-TB): a pan-Canadian prospective cohort study
CIHR · 2025 · Nominated PI
- $313,650
Risk Assessment and Determinants of Tuberculosis Associated Respiratory Impairment and Disability (RADAR-TB): A Systematic Review and Individual Participant Data Meta-Analysis
CIHR · 2024 · Nominated PI
Enhanced Multi-modal, Patient-Centred treatment Option Pathway for Women Experiencing Sleep-Disordered Breathing in PRegnancy (EMPOWER-SDB): A Type 1 Hybrid Effectiveness-Implementation Trial
Principal investigators: Pamidi, Sushmita; Almeida, Fernanda R; Fontaine, Guillaume; Huynh, Nelly
Keywords: Adherence; Cpap; Efficacy; Implementation Outcomes; Mandibular Advancement Splint; Pregnancy; Pregnancy Complications; Sleep-Disordered Breathing
Functional Outcomes, Lung health, and Livelihood Outcomes among people With Tuberculosis (FOLLOW-TB): a pan-Canadian prospective cohort study
Principal investigators: Campbell, Jonathon; Brode, Sarah K; Johnston, James C; Law, Stephanie
Keywords: Lung Health; Public Health; Quality Of Life; Sequelae; Tuberculosis
Risk Assessment and Determinants of Tuberculosis Associated Respiratory Impairment and Disability (RADAR-TB): A Systematic Review and Individual Participant Data Meta-Analysis
Principal investigators: Campbell, Jonathon; Johnston, James C
Keywords: Risk-Factors; Risk-Prediction; Sequelae; Tuberculosis
Legal Framework and Impact Analyses: Groundwork for a Diabetes Prevention and Remission Program in Quebec
Principal investigators: Dasgupta, Kaberi; Hanson, Kimberley
Keywords: Diabetes Prevention Programs; Diabetes Remission Programs; Economic Analysis; Legal Analysis
Immunogenicity and safety of COVID-19 vaccine Co-administration and Interval in Immunocompromised hosts (CO2I2 Trial).
Principal investigators: Sapir-Pichhadze, Ruth; Stalker, Leanne; Colmegna, Ines; Costiniuk, Cecilia T; Suri, Rita
Keywords: Cellular Immunity; Cost Effectiveness; Covid-19; Humoral Immunity; Immunogenicity; Influenza; Neutralization; Quality Of Life; Safety; Vaccine
Finding the right balance: An adaptive trial to identify the safest regimen with the shortest duration for TB prevention (treatment of TB Infection)
Principal investigators: Menzies, Richard; Campbell, Jonathon; Fox, Gregory; Golchi, Shirin; Johnston, James C; Law, Stephanie; Long, Richard; Lupien, Andréanne; Ruslami, Rovina
Keywords: Acceptability; Adaptive Trial; Cost-Effectiveness; Multi-Arm Trial; Multicentre Trial; Randomized Trial; Safety; Tolerability; Tuberculosis; Tuberculosis Prevention
Finding the right balance: An adaptive trial to identify the safest regimen with the shortest duration for TB prevention (treatment of TB Infection)
Principal investigators: Menzies, Richard; Campbell, Jonathon; Fox, Gregory; Golchi, Shirin; Johnston, James C; Law, Stephanie; Long, Richard; Lupien, Andréanne; Ruslami, Rovina
Keywords: Acceptability; Adaptive Trial; Cost-Effectiveness; Multi-Arm Trial; Multicentre Trial; Randomized Trial; Safety; Tolerability; Tuberculosis; Tuberculosis Prevention
Immunogenicity and safety of COVID-19 vaccine Co-administration and Interval in Immunocompromised hosts (CO2I2 Trial).
Principal investigators: Sapir-Pichhadze, Ruth; Stalker, Leanne; Colmegna, Ines; Costiniuk, Cecilia T; Suri, Rita
Keywords: Cellular Immunity; Cost Effectiveness; Covid-19; Humoral Immunity; Immunogenicity; Influenza; Neutralization; Quality Of Life; Safety; Vaccine
A Key Step to Eliminating Tuberculosis in Canada: Informing the Implementation and Scale-up of Tuberculosis Preventive Treatment
Principal investigators: Campbell, Jonathon; Brode, Sarah K; Johnston, James C
Keywords: Prevention; Risk-Benefit; Scale-Up Science; Tuberculosis
Tuberculosis in Canada: Modeling to Inform Elimination
Principal investigators: Schwartzman, Kevin; Johnston, James C
Keywords: Cost-Effectiveness; Decision Analysis; Ethics; Migrants; Prediction; Public Health; Screening; Tuberculosis
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.